BioVie Inc. (NASDAQ:BIVIW – Get Free Report)’s share price crossed below its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $0.32 and traded as low as $0.2908. BioVie shares last traded at $0.2908, with a volume of 903 shares changing hands.
BioVie Price Performance
The firm has a 50-day moving average price of $0.31 and a two-hundred day moving average price of $0.32.
BioVie Inc is a clinical-stage biopharmaceutical company developing therapies for neurological and liver-related disorders. Its research focuses on conditions associated with chronic inflammation, insulin resistance, neurodegeneration and impaired liver function, areas in which the company seeks to address significant unmet medical needs.
The company’s lead investigational product is bezisterim, also known as NE3107, an orally administered compound being studied for neurodegenerative diseases, including Alzheimer’s disease and Parkinson’s disease.
Read More
- Five stocks we like better than BioVie
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
Receive News & Ratings for BioVie Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioVie and related companies with MarketBeat.com's FREE daily email newsletter.
